Nature Food, 5(9), 787-797
All study participants provided written consent, and the study protocol was approved by the research ethics board at Nanfang Hospital, Southern Medical University, Guangzhou, China, in accordance with the principles of the Declaration of Helsinki
Tirzepatide, a dual GIP/GLP-1 agonist, has demonstrated superior weight loss efficacy, reshaping prescriber preferences in obesity management
There are currently eight types available to treat type 2 diabetes, each administered either as oral or injectable medications: To date, FDA approval has only been granted to two of Novo Nordisks GLP-1s to be used as a weight loss drug
This hormone is secreted by the intestines in response to food intake and plays a crucial role in glucose metabolism
Discreet fulfillment When prescribed, fulfillment is handled through the partnered pharmacy with discreet packaging